The FDA's radiofrequency microneedling notice, and what it changed about the consultation
In October the FDA published a safety communication about radiofrequency microneedling, and two professional societies followed it by recommending consent language that names the reported risks. This is what that changed about how an RF appointment gets screened, consented and scheduled here.
Somebody sent me the link last October and asked whether she should cancel. The FDA had published a safety communication about radiofrequency microneedling devices, and it is one of the few documents about this category that was not written by somebody selling something.
There is an RF device in this room. That is the reason to write about the notice rather than wait for it to be forgotten.
What did the FDA actually say?
It said the agency had received reports of serious complications associated with certain uses of radiofrequency microneedling: burns, scarring, fat loss, disfigurement and nerve damage, some of which required surgical repair or other medical intervention. It asked patients, caregivers and providers to report complications while its evaluation continues, and it said the procedure should be performed by a licensed health care provider with training and experience in its use.
It was a safety communication rather than a recall. No device was taken off the market and the evaluation is ongoing. The document is public, and anyone considering this kind of appointment is better served reading it directly than reading my summary of it.
Does that mean the device is unsafe?
It means that who is operating the device, and what was screened for before it was switched on, matter more than which platform is in the room. That was true before the notice and it is still true after it. A device does not know who is sitting in front of it. It does what the settings tell it to do, at the depth somebody selected, on skin that was either assessed properly or was not.
Two rooms a mile apart can run the same platform and screen for entirely different things, and the screening is the part nobody photographs.
What does the clearance actually cover?
QuantumRF is cleared under K240780 and K251254, and the indication reads "coagulation/contraction of soft tissue or hemostasis." That is the whole of it.
It does not say skin laxity. It does not say skin tightening. Both phrases run through much of the advertising for this class of device, neither is in the clearance, and so neither is going to appear on this site or in this room. What I can describe is what the assessment covers and what the appointment involves. What the device does to tissue is not mine to promise.
What changed here after the notice?
The consent got longer and more specific. Two professional societies in the field followed the communication by recommending that consent forms for this procedure name the reported risks explicitly, and doing that here mostly meant putting in writing what had previously been said out loud.
- Burns, scarring, fat loss, disfigurement and nerve damage are named in the consent, in writing, and read before the day of the appointment rather than while somebody is already numb and gowned.
- Settings and depths are recorded pass by pass and kept in the chart, so a second appointment continues the first rather than starting from a fresh guess.
- A check-in is scheduled at the time of booking instead of being left to be requested.
- The consultation states plainly what the clearance says and what it does not say.
What did not change is who performs it. I am a nurse practitioner, this is a solo injecting practice, and I hold the handpiece at the first appointment and at the fifth. On that point the notice did not require any rearranging here.
Who does not get booked for this?
Several groups, and the list is worked through at the consultation rather than on the day:
- Anyone with an implanted electronic device: pacemaker, defibrillator, neurostimulator. That is a decline rather than a delay.
- Anyone recently on isotretinoin. Generally deferred, and the interval is decided per person rather than by a rule of thumb.
- Active infection, an open lesion or a cold sore in the treatment area. Deferred until it has settled.
- A history of keloid scarring. For most people in that group this is not the right treatment at all, rather than one to postpone.
- Pregnancy or breastfeeding. Deferred.
- A current tan or recent sun on the area. In a Boca August that is close to automatic.
- Anyone with an event inside about six weeks. Recovery is not something to schedule around a wedding.
- Anyone who arrived asking for a device by name rather than describing what they want to be different. That conversation usually ends somewhere else, and sometimes it ends with nothing booked at all.
What it costs, and when the number is settled
Morpheus8 Burst and QuantumRF are quoted at the consultation, as a whole course, and the figure you are given is fixed before anything is booked. It is the same arithmetic for everybody who walks in.
The total is agreed before consent is signed. A number introduced after somebody is already numb is not a number anybody agreed to.
Three questions are worth asking of any practice with an RF device in the room, including this one: which clearance the device is used under, who is holding the handpiece on the day, and what would make them decline to treat. The third answer is the one that carries information. A practice that cannot name anything it turns away is describing a schedule rather than a screening.
Questions people ask about this
Does the FDA notice mean an RF microneedling appointment should be cancelled?
Generally no, and cancellation is not really the question the notice raises. It raises questions about screening, settings and who performs the treatment. Anyone unsure is welcome to bring the document to a consultation and go through it line by line before anything is booked.
Is Morpheus8 the same thing as QuantumRF?
They are different platforms in the same broad category, and they are quoted separately here, each as a whole course, fixed before anything is booked. Which one is discussed depends on the assessment, and in a fair number of cases the answer is neither.
Who performs the treatment?
I do, at every appointment. I am a nurse practitioner and this is a solo injecting practice, so there is no rotation of providers and nothing about the treatment is delegated.
Related
Next
A unit is not a unit
Book a consultation with Jamie.
The consultation is where we work out what is right for you, and you will always hear exactly what I would do, and why.
Payment plans are available through Affirm and Cherry, arranged with the lender at your consultation and never sprung on the day.